Clinical Trial Update: A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia B [Phase 3]

View source ↗

Summary

Phase 3 trial of Nonacog Beta Pegol (N9-GP) in Chinese patients with Hemophilia B has completed, with results posted for evaluating treatment and prevention of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Rebinyn (nonacog beta pegol)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Haemophilia B | Phase 3 | Status: COMPLETED | Results posted: 2025-05-31